Acadia Pharmaceuticals reported $663M in Equity Capital and Reserves for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US $ 663M 25M
Adamas Pharmaceuticals ADMS:US $ -25M 9M
Alexion Pharmaceuticals ALXN:US $ 10490.8M 1257M
ALKERMES ALKS:US $ 1084.36M 22.51M
Alnylam Pharmaceuticals ALNY:US $ 1215.02M 184.7M
Biogen BIIB:US $ 10758.5M 550.2M
Biomarin Pharmaceutical BMRN:US $ 3236.68M 3.28M
Bristol Myers Squibb BMY:US $ 49094M 817M
Corcept Therapeutics CORT:US $ 453M 44M
Cytokinetics CYTK:US $ 149.6M 227.68M
Eisai 4523:JP Y 678648M 521M
Eli Lilly And LLY:US $ 4092.9M 1014.1M
Gw Pharmaceuticals GWPH:US $ 734.45M 17.51M
Intercept Pharmaceuticals ICPT:US $ -78.8M 44.08M
Johnson & Johnson JNJ:US $ 64473M 1495M
Neurocrine Biosciences NBIX:US $ 831M 131M
Pfizer PFE:US $ 64336M 690M
Prothena PRTA:US $ 209.51M 24.93M
Ptc Therapeutics PTCT:US $ 572.49M 43.76M
Sarepta Therapeutics SRPT:US $ 1042M 102M
Seattle Genetics SGEN:US $ 2258.03M 443.95M
Ultragenyx Pharmaceutical RARE:US $ 695.59M 86.44M
Vanda Pharmaceuticals VNDA:US $ 431.58M 15.2M
Vertex Pharmaceuticals VRTX:US $ 7519.24M 1057.59M
YTE INCY:US $ 2344.6M 406.88M
Zogenix ZGNX:US $ 405M 45M